ELIOS laser used during cataract surgery to treat glaucoma
Official title: Efficacy and Safety of the ELIOS Laser in Combined Cataract and Glaucoma Surgery
Run by Hôpital Privé de la Baie · NCT06760169 · Data updated 2026-11-12
This trial will test whether using the ELIOS excimer laser at the time of cataract surgery lowers eye pressure in adults with early to moderate open-angle glaucoma.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 46 (estimated) |
| Sponsor | Hôpital Privé de la Baie Academic / other |
| Locations | 1 site (Avranches) |
| Status | Recruiting |
| Started | January 5, 2025 |
| Main results expected | December 31, 2027 |
| Study ends | February 28, 2028 |
| Registry record updated | September 30, 2026 |
| Trial ID | NCT06760169 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with visually significant cataract and early to moderate primary or certain secondary open-angle glaucomas who have open iridocorneal angles and no history of intraocular surgery in the operative quadrant.
✕Probably not a fit
Patients with advanced glaucoma (visual field mean deviation worse than −12 dB), angle‑closure glaucoma, severe ocular comorbidities, previous intraocular surgery in the target quadrant, or very poor vision are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional, single-site procedure combines standard cataract extraction with an ab interno ELIOS excimer laser goniotomy to create ten 210 µm microchannels in the trabecular meshwork and inner wall of Schlemm’s canal using a 308 nm wavelength. The approach is a form of micro‑invasive glaucoma surgery (MIGS) intended to improve trabecular outflow and reduce intraocular pressure while avoiding the higher complication rates of traditional filtering surgery. Adult patients with visually significant cataract and open-angle glaucoma (Shaffer grade 2–4) are eligible, excluding those with advanced glaucoma or prior intraocular surgery in the intended quadrant. Outcomes will include intraocular pressure change and procedure-related safety events monitored during postoperative follow-up.
Why it matters
Potential benefit: If successful, the procedure could lower eye pressure and reduce the need for glaucoma medications while carrying fewer risks than more invasive glaucoma surgeries.
How similar studies have gone: Micro‑invasive glaucoma surgeries, including various goniotomy techniques, have shown benefit in lowering intraocular pressure, while the ELIOS excimer laser approach is newer with limited but emerging published results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients ≥ 18 years of age who agree to take part in the study and have signed an informed consent form * Visually significant cataract with indication for surgery * Primary open-angle glaucoma, or secondary open-angle glaucoma (pseudoexfoliative glaucoma or pigmentary glaucoma) with indication for cataract surgery. * Open iridocorneal angle (Shaffer classification grade 2-4) * Early to moderate glaucoma (advanced glaucoma, with MD from VFs worse than -12dB, will be excluded) Exclusion Criteria: * Presence of severe systemic pathologies 2024-A01891-46\_Protocol\_V6\_21112024\_Elios Page 20 / 58 * Pregnant or breastfeeding women * \<18 years of age * Presence of other ophthalmological pathologies (except cataracts), and exclusion of severe dry eye. * History of intraocular surgery, trauma, or conjunctival scarring in the quadrant intended for surgery * Visual acuity worse than "counting fingers". * Closure of the iridocorneal angle (and angle-closure glaucoma), angle-closure glaucoma secondary to iridocorneal synechiae, neovascular glaucoma or neovascularization of the iris. * Normal-pressure glaucoma * Pachymetry \< 490 um or \> 620 μm * Glaucomatous visual field with mean deviation worse than ≤-12 dB * IOP \> 35 mmHg * Autoimmune disorder, especially collagenosis * Patient under protective supervision * Patient not covered by a social security scheme
Where it's running
-
Hôpital Privé de la Baie
Avranches, France Recruiting
Study contacts
- Study coordinator: Ana Miguel, MD
- Email: myworld_ana@hotmail.com
- Phone: +33787016187
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Balance training for people with glaucoma
A randomized study tests whether a structured eight-week balance program helps adults with glaucoma improve balance, reduce fall risk, and lessen fear of falling.
-
Eye drops Rhopressa vs Timolol to protect nerve cells in glaucoma
In adults with open-angle glaucoma, this study tests whether Rhopressa helps preserve retinal nerve cells better than Timolol while both lower eye pressure.
-
Comparison of FT-1000 non-contact tonometry with Goldmann applanation tonometry in glaucoma patients
This study tests whether the FT-1000 non-contact tonometer gives measurements that agree with the Goldmann applanation tonometer in adults with glaucoma.
-
Removing the ripcord from a glaucoma drainage device after 3 months
This study tests whether removing the ripcord from an implanted glaucoma drainage device changes eye pressure for adults with open-angle glaucoma.
-
Glaucoma and Brain Changes: How Brain Structure and Size See What Glaucoma Is Doing
This study tests whether glaucoma is linked to broader brain changes by comparing brain MRI and eye health over time in people with glaucoma and matched controls.
-
Long-Term Results After Ab-interno Trabeculotomy for Glaucoma
This study tests whether ab-interno trabeculotomy with the Trabectome can provide sustained intraocular pressure reduction in glaucoma patients who had the procedure between 2019 and 2021.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.